Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$21.50

0.27 (1.27%)

11:54
04/12/18
04/12
11:54
04/12/18
11:54

Raymond James throws in towel, says sell Bed Bath & Beyond after guidance

Shares of Bed Bath & Beyond (BBBY) are sliding after the company announced better than expected fourth quarter results but issued a weaker 2018 forecast. Following the news, several Wall Street analysts cut their price targets on the stock, while Raymond James analyst Beryl Bugatch downgraded Bed Bath & Beyond to Underperform, a sell-equivalent rating. RESULTS: Last night, Bed Bath & Beyond reported fourth quarter earnings per share of $1.48 and revenue of approximately $3.7B, both above consensus of $1.39 and $3.68B, respectively. However, the company also said that it sees FY18 EPS in a low-to-mid $2 range, with consensus at $2.76. Additionally, Bed Bath & Beyond outlined its "roadmap for continuing the evolution of its foundational structure" with the goals of: growing its comparable sales, which it expects to begin in fiscal 2018; moderating the declines in its operating profit and net earnings per diluted share, in fiscal 2018 and fiscal 2019; and growing its net earnings per diluted share by fiscal 2020. SELL, SAYS RAYMOND JAMES: In a post-earnings note, Raymond James' Bugatch downgraded Bed Bath & Beyond to Underperform from Market Perform. The analyst noted that the company's management announced multiple initiatives ranging from new store concepts to new organizational structures, to new investments in technology that will come at a cost, as underscored by management's view for continuing operating profit declines in FY18 and FY19. Despite the array of initiatives announced, a key issue for the analyst is that the fleet of over 1,000 legacy Bed Bath & Beyond stores continue to deliver in-store mid-single-digit comparable sales declines. Bugatch argued that it is "Beyond" him that management did not cite a remodeling of its flagship store base that he finds "increasingly unattractive" due to being dated, cluttered and crowded. Without some underlying growth in management generated earnings over the next two years, shareholder value is likely to erode further, he added. Nonetheless, Bugatch pointed out that at its current valuation, Bed Bath may attract activist interest. TARGETS CUT: Meanwhile, Morgan Stanley analyst Simeon Gutman lowered his price target for Bed Bath & Beyond to $16 from $20 as he is not convinced its revenue will respond to the company's initiatives. The analyst told investors that beyond a lift from the Babies R' Us bankruptcy, it is hard for him to see how the company can drive positive same-store sales without the aid of promotions. Gutman reiterated an Underweight rating on the shares. His peer at JPMorgan also lowered his price target for Bed Bath & Beyond to $16 from $18. Analyst Christopher Horvers noted that the company's negative comparable sales in Q4 and over the past two quarters are "particularly disappointing" as is the acceleration in gross margin declines. The analyst also kept an Underweight rating on the shares. Additionally, Wedbush analyst Seth Basham, Credit Suisse's Seth Sigman, and Loop Capital's Anthony Chukumba all lowered their price targets on the name to $18, $20 and $18, respectively, while reiterating neutral-equivalent ratings. PRICE ACTION: In late morning trading, shares of Bed Bath & Beyond dropped over 19% to $17.39.

BBBY Bed Bath & Beyond
$21.50

0.27 (1.27%)

04/12/18
RAJA
04/12/18
DOWNGRADE
RAJA
Underperform
Bed Bath & Beyond downgraded to Underperform at Raymond James
04/12/18
LOOP
04/12/18
NO CHANGE
LOOP
Bed Bath & Beyond price target lowered to $18 from $23 at Loop
Loop Capital analyst Anthony Chukumba lowered his price target on Bed Bath & Beyond to $18 from $23 and maintained a Hold rating following the company's "much worse-than-expected" FY18 earnings guidance and subsequent sell-off.
04/12/18
04/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Paycom (PAYC) downgraded to Equal Weight from Overweight at Barclays with analyst Raimo Lenschow saying the stock has meaningfully outperformed over the last year while estimate revisions have been limited. 2. J.B. Hunt (JBHT) downgraded to Sector Weight from Overweight at KeyBanc. 3. Devon Energy (DVN) downgraded to Outperform from Focus List at Scotia Howard Weil. 4. PJT Partners (PJT) downgraded to Hold from Buy at Sandler O'Neill with analyst Sumeet Mody saying after appreciating 17% year-to-date, the stock is approaching fair value. 5. Bed Bath & Beyond (BBBY) downgraded to Underperform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/18
04/12/18
DOWNGRADE

Underperform
Bed Bath & Beyond downgraded to Underperform at Raymond James
As previously reported, Raymond James analyst Beryl Bugatch downgraded Bed Bath & Beyond to Underperform from Market Perform following quarterly results. Despite the array of initiatives announced by management, a key issue for the analyst is that the fleet of over 1,000 legacy Bed Bath & Beyond stores continue to deliver in-store mid-single-digit comp sales declines. Without some underlying growth in management generated earnings over the next two years, shareholder value is likely to erode further, he adds. Nonetheless, Bugatch points out that at its current valuation, Bed Bath may attract "activist" interest.

TODAY'S FREE FLY STORIES

PZZA

Papa John's

$57.31

1.01 (1.79%)

14:40
11/15/18
11/15
14:40
11/15/18
14:40
Hot Stocks
Papa John's up 5% as takeover rumors resurface »

Shares of Papa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ETH

Ethan Allen

$19.04

-0.315 (-1.63%)

14:34
11/15/18
11/15
14:34
11/15/18
14:34
Hot Stocks
Ethan Allen design center set to open in the Superior Marketplace »

Ethan Allen has relocated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

Ziopharm

$2.95

0.27 (10.07%)

14:31
11/15/18
11/15
14:31
11/15/18
14:31
Upgrade
Ziopharm rating change  »

Ziopharm upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$56.36

0.06 (0.11%)

14:31
11/15/18
11/15
14:31
11/15/18
14:31
Technical Analysis
Technical Take: Papa John's spikes in last 5 minutes »

The shares have spiked to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

WFC

Wells Fargo

$52.69

0.54 (1.04%)

14:28
11/15/18
11/15
14:28
11/15/18
14:28
Periodicals
Wells Fargo to slash roughly 1,000 jobs in U.S., Reuters reports »

Wells Fargo said that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

CCO

Clear Channel Outdoor

$5.49

0.17 (3.20%)

, IHRT

iHeartMedia

$0.00

(0.00%)

14:27
11/15/18
11/15
14:27
11/15/18
14:27
Recommendations
Clear Channel Outdoor, iHeartMedia analyst commentary  »

Barrington says Clear…

CCO

Clear Channel Outdoor

$5.49

0.17 (3.20%)

IHRT

iHeartMedia

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$13.26

-0.36 (-2.64%)

14:20
11/15/18
11/15
14:20
11/15/18
14:20
Options
Large option blocks in Bed, Bath and Beyond as shares reach 52-week lows »

Large option blocks in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
11/15/18
11/15
14:20
11/15/18
14:20
General news
Canada manufacturing preview »

Canada manufacturing…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/15/18
11/15
14:17
11/15/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/15/18
11/15
14:16
11/15/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.19

0.69 (1.09%)

14:08
11/15/18
11/15
14:08
11/15/18
14:08
Hot Stocks
Citi reports October credit loss 2.63% vs. 2.42% last month »

Reports October 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

DPZ

Domino's Pizza

14:04
11/15/18
11/15
14:04
11/15/18
14:04
Recommendations
Domino's Pizza analyst commentary  »

Stephens says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ZIOP

Ziopharm

$2.85

0.17 (6.34%)

14:04
11/15/18
11/15
14:04
11/15/18
14:04
Upgrade
Ziopharm rating change  »

Ziopharm upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$129.48

0.715 (0.56%)

14:02
11/15/18
11/15
14:02
11/15/18
14:02
Hot Stocks
Motorola Solutions boosts quarterly dividend by 10% to 57c »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

FB

Facebook

$143.17

-1.08 (-0.75%)

13:58
11/15/18
11/15
13:58
11/15/18
13:58
Hot Stocks
Facebook board admits to pushing CEO, COO to 'move faster' on interference »

The board of Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

SPY

SPDR S&P 500 ETF Trust

$271.90

1.71 (0.63%)

, SPX

S&P 500

$0.00

(0.00%)

13:57
11/15/18
11/15
13:57
11/15/18
13:57
Periodicals
U.S., China step up effort to strike G20 truce on trade, FT reports »

The U.S. and China have…

SPY

SPDR S&P 500 ETF Trust

$271.90

1.71 (0.63%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
11/15/18
11/15
13:55
11/15/18
13:55
General news
U.S. equities snapped back into the green »

U.S. equities snapped…

IAC

IAC

$180.83

0.23 (0.13%)

13:50
11/15/18
11/15
13:50
11/15/18
13:50
Hot Stocks
Rock Holdings acquires Dictionary.com, Thesaurus.com from IAC »

Dan Gilbert's Rock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$46.20

1.49 (3.33%)

13:48
11/15/18
11/15
13:48
11/15/18
13:48
Conference/Events
Fluor to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

RCMT

RCM Technologies

$4.03

0.03 (0.75%)

13:48
11/15/18
11/15
13:48
11/15/18
13:48
Hot Stocks
RCM Technologies announces acquisition of Thermal Kinetics, terms not disclosed »

RCM Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARE

Ultragenyx

$51.33

2.92 (6.03%)

13:45
11/15/18
11/15
13:45
11/15/18
13:45
Conference/Events
Ultragenyx haqs a conference call hosted by JPMorgan »

JPMorgan Analyst Kasimov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

VIAB

Viacom

$31.87

0.07 (0.22%)

, VIA

Viacom

$35.23

-0.1 (-0.28%)

13:41
11/15/18
11/15
13:41
11/15/18
13:41
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

VIAB

Viacom

$31.87

0.07 (0.22%)

VIA

Viacom

$35.23

-0.1 (-0.28%)

HP

Helmerich & Payne

$59.45

1.15 (1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 16

    Nov

  • 04

    Dec

NVDA

Nvidia

$201.85

4.63 (2.35%)

, AMAT

Applied Materials

$34.94

1.35 (4.02%)

13:41
11/15/18
11/15
13:41
11/15/18
13:41
Earnings
Notable companies reporting after market close »

Notable companies…

NVDA

Nvidia

$201.85

4.63 (2.35%)

AMAT

Applied Materials

$34.94

1.35 (4.02%)

POST

Post Holdings

$91.15

-0.43 (-0.47%)

WSM

Williams-Sonoma

$60.67

-1.09 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

PPL

PPL Corp.

$30.56

-1.63 (-5.06%)

13:35
11/15/18
11/15
13:35
11/15/18
13:35
Options
PPL Corp. put volume heavy and directionally bearish »

Bearish flow noted in PPL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$19.07

-6.59 (-25.68%)

13:32
11/15/18
11/15
13:32
11/15/18
13:32
Recommendations
PG&E analyst commentary  »

PG&E recent weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.